Literature DB >> 947203

[New findings on the efficacy and mode of action of the horse chestnut saponin escin].

M Rothkopf, G Vogel.   

Abstract

In order to complete previous results of the efficacy of the horse chestnut saponin escin, its activity was tested on two further models of inflammation: the rat serous peritonitis provoked by i.p. injection of formalin solution, and the rat serous pleurisy provoked by intrapleural injection of Evans Blue/carrageenan. The results showed escin to be an anti-exudative substance with regard to its exudation inhibitory effect determined by the reduction of exudative fluid. As to peritonitis the diminution of protein permeation into the abdominal cavity was determined: with increasing doses escin tended to prevent more efficiently the diffusion of small molecules than the permeation of large molecules. The hypothesis that escin has an effect on the vascular walls in the sense of a "sealing" effect on the capillaries was tested on the following model: the permeability of the plasma-lymph barrier of the hind leg of the rabbit was enhanced by injection of bradykinin. Escin antagonised the bradykinin effect dose-dependently determined by the depression of the raised lymph-flow by about 70%.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 947203

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  5 in total

1.  Phenyl isothiocyanate pleurisy in rats--a model for the evaluation of anti-exudative substances.

Authors:  M Rothkopf-Ischebeck
Journal:  Agents Actions       Date:  1978-12

2.  Escin/diethylammonium salicylate/heparin combination gels for the topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study.

Authors:  D Wetzel; W Menke; R Dieter; V Smasal; B Giannetti; M Bulitta
Journal:  Br J Sports Med       Date:  2002-06       Impact factor: 13.800

3.  Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathway.

Authors:  Kuzhuvelil B Harikumar; Bokyung Sung; Manoj K Pandey; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Mol Pharmacol       Date:  2010-01-26       Impact factor: 4.436

Review 4.  Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties.

Authors:  Luca Gallelli
Journal:  Drug Des Devel Ther       Date:  2019-09-27       Impact factor: 4.162

5.  Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway.

Authors:  A Rimmon; A Vexler; L Berkovich; G Earon; I Ron; S Lev-Ari
Journal:  Biochem Res Int       Date:  2013-10-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.